On Tuesday, academics and researchers interested in stroke rehabilitation gathered for a specialist conference hosted by the University of Central Lancashire (UCLan). The Organisation for Psychological Research Into Stroke (OPSYRIS) event showcased a broad range of research highlighting aspects of psychological and neuropsychological stroke care and research.
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
The aim of this study is to develop a fatigue management programme to improve stroke survivors' knowledge of post stroke fatigue (PSF) and to identify ways of managing it.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC). Published today, the AMRC have launched a new booklet outling highlighting how vital health information is to enable researchers to prevent, diagnose and treat disease and improve care.
Problems of mood, thinking and memory are common after a stroke. There has been limited research around these issues. This work aims to answer fundamental questions around who develops these problems and how they recover.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
Published in the journal, Lancet Neurology, a new study suggests that understanding stroke severity, as well as time to treatment, is key to delivering effective and safe thrombolysis treatment.
Universty of Oxford News Release:Immediate aspirin after mini-stroke substantially reduces risk of major stroke
Video interview highlights from ten key trials that presented at ESOC 2016.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.